Drug Topics E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
  Drug Topics E-News
 
October 06, 2009
IN THIS ISSUE
NCPA begs IRS action
Cardinal expands services
HealthTrans enacts changes
Roche talks dosing
  TOP SEARCHES: CE // Diabetes // Asthma

Join the Drug Topics editorial advisory council!
We are revamping our editorial board to include “man/woman on the street” pharmacists—people like you, who work in the trenches. Won’t you join us? If you come on board, we would list your name on our masthead, invite you to advise us on story ideas, ask you provide blogs or (short) commentaries in the magazine, and participate in a virtual roundtable of topics, which we’d publish in the magazine.

This would not take up a great deal of your time, yet it would provide a great service to your colleagues and the profession. If you’d like to do this, send your full contact information, and a CV or resume, to Margaret Mulligan, editor-in-chief at mmulligan@advanstar.com. I look forward to hearing from you, and thank you for your interest in Drug Topics—the voice of the pharmacist.

NCPA urges IRS to act on FSA rules
The National Community Pharmacists Association (NCPA) is urging the IRS to quickly act on flexible spending account (FSA) regulations that are disrupting pharmacies’ FSA debit card transactions. More....

Cardinal Health expands services for hospital pharmacies
Cardinal Health is hoping that its newly expanded services offered to hospital pharmacies helps customers to make improvements to their work flow. Pharmacy directors can now select only specific services they need to meet their needs, a new option from the company. More...

HealthTrans makes changes to average wholesale prices
HealthTrans, a healthcare management solutions comapny, recently announced the completion of all necessary modifications to ensure market readiness for changes to Average Wholesale Prices (AWP). More...

Roche addressed Tamiflu dosing discrepancies
Roche Laboratories recently released a statement to healthcare professionals regarding Tamiflu (oseltamivir phosphate) recommendations. More...


Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Law

Key Topic Updates

Survey

How much input do you have into retail business decisions at your pharmacy?

A lot
 
29%
Some   20%
None   51%

This month we would like to know...

Do you ever advise trying a comparable OTC drug when a patient has a script in hand?

Yes
No

Click here to vote


Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.

Follow us on Twitter.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.